E-LIB Suche - Ergebnisse für: Bellmunt, J.

1

ESMO Clinical Practice Guideline interim update on first-li..:

Powles, T. ; Bellmunt, J. ; Comperat, E....
Annals of Oncology. 35 (2024) 6 - p. 485-490 , 2024

Link: https://doi.org/10.1016/..

2

8P Factors associated with primary progression in patients ..:

Jindal, T. ; Jiang, C. ; Alhalabi, O....
ESMO Open. 9 (2024) - p. 102263 , 2024

Link: https://doi.org/10.1016/..

3

Efficacy and safety of pembrolizumab in metastatic urotheli..:

Balar, A.V. ; Castellano, D.E. ; Grivas, P....
Annals of Oncology. 34 (2023) 3 - p. 289-299 , 2023

Link: https://doi.org/10.1016/..

4

Comparison of the Genomic Alterations in Upper-tract and Bl..:

Yekeduz, E. ; Saliby, R.M. ; Shah, V....
European Urology Open Science. 57 (2023) - p. S11 , 2023

Link: https://doi.org/10.1016/..

5

EE408 Pharmacoeconomic Analysis of Abrocitinib in Patients ..:

Campos Domínguez, M. ; Herranz Pinto, P. ; Romero Jiménez, R.M....
Value in Health. 26 (2023) 12 - p. S129 , 2023

Link: https://doi.org/10.1016/..

6

EE509 Burden of Disease in Low-Risk Myelodysplastic Syndrom..:

Valcárcel, D ; Montoro, MJ ; Tormo, M...
Value in Health. 25 (2022) 12 - p. S155-S156 , 2022

Link: https://doi.org/10.1016/..

7

Non-muscle-invasive micropapillary bladder cancer has a dis..:

De Jong, J.J. ; Valderrama, B.P. ; Perera, J....
European Urology. 81 (2022) - p. S124 , 2022

Link: https://doi.org/10.1016/..

8

IMvigor010: Updated analysis of Overall Survival (OS) by ci..:

Powles, T. ; June Assaf, Z. ; Mariathasan, S....
European Urology Open Science. 45 (2022) - p. S216-S217 , 2022

Link: https://doi.org/10.1016/..

9

Latest progress in molecular biology and treatment in genit..:

González-del-Alba, A. ; Arranz, J. Á. ; Bellmunt, J....
Clinical and Translational Oncology. 22 (2020) 12 - p. 2175-2195 , 2020

Link: https://doi.org/10.1007/..

10

An international collaborative study from the EAU and ESMO ..:

MacLennan, S. ; Bruins, H.M. ; Plass, K.M.J....
European Urology Supplements. 18 (2019) 1 - p. e2124-e2125 , 2019

Link: https://doi.org/10.1016/..

11

Adjuvant chemotherapy improves survival outcomes in patient..:

Zamboni, S. ; Baumeister, P. ; Aziz, A....
European Urology Supplements. 18 (2019) 9 - p. e3244 , 2019

Link: https://doi.org/10.1016/..

12

Neo-adjUvant veRsus AdjuvaNt chemotherapy in upper tract Ur..:

Palou, J. ; Maroto, P. ; Osanto, S....
European Urology Supplements. 18 (2019) 1 - p. e1847 , 2019

Link: https://doi.org/10.1016/..

13

Impact of contemporary patterns of chemotherapy utilization..:

Bamias, A. ; Tzannis, K. ; Harshman, L.C....
Annals of Oncology. 30 (2019) 11 - p. 1841 , 2019

Link: https://doi.org/10.1093/..

14

Randomized phase III KEYNOTE-045 trial of pembrolizumab ver..:

Fradet, Y. ; Bellmunt, J. ; Vaughn, D.J....
Annals of Oncology. 30 (2019) 6 - p. 970-976 , 2019

Link: https://doi.org/10.1093/..

15

What is the negative predictive value of multiparametric ma..:

Moldovan, P. ; Van Den Broeck, T. ; Sylvester, R....
European Urology Supplements. 17 (2018) 2 - p. e1727-e1728 , 2018

Link: https://doi.org/10.1016/..